Cite

MLA Citation

    Giovanni Novi et al.. “Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS.” Neurology, vol. 7, no. 3, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100105911147.0x000004
  
Back to record